Andre Liber
University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andre Liber.
Brain Behavior and Evolution | 2014
Einat Hauzman; Daniela Maria Oliveira Bonci; Sonia Regina Grötzner; Maritana Mela; Andre Liber; Sonia L. Martins; Dora Fix Ventura
The diurnal Dipsadidae snakes Philodryas olfersii and P. patagoniensis are closely related in their phylogeny but inhabit different ecological niches. P. olfersii is arboreal, whereas P. patagoniensis is preferentially terrestrial. The goal of the present study was to compare the density and topography of neurons, photoreceptors, and cells in the ganglion cell layer in the retinas of these two species using immunohistochemistry and Nissl staining procedures and estimate the spatial resolving power of their eyes based on the ganglion cell peak density. Four morphologically distinct types of cones were observed by scanning electron microscopy, 3 of which were labeled with anti-opsin antibodies: large single cones and double cones labeled by the antibody JH492 and small single cones labeled by the antibody JH455. The average densities of photoreceptors and neurons in the ganglion cell layer were similar in both species (∼10,000 and 7,000 cells·mm-2, respectively). The estimated spatial resolving power was also similar, ranging from 2.4 to 2.7 cycles·degree-1. However, the distribution of neurons had different specializations. In the arboreal P. olfersii, the isodensity maps had a horizontal visual streak, with a peak density in the central region and a lower density in the dorsal retina. This organization might be relevant for locomotion and hunting behavior in the arboreal layer. In the terrestrial P. patagoniensis, a concentric pattern of decreasing cell density emanated from an area centralis located in the naso-ventral retina. Lower densities were observed in the dorsal region. The ventrally high density improves the resolution in the superior visual field and may be an important adaptation for terrestrial snakes to perceive the approach of predators from above.
Journal of Ocular Pharmacology and Therapeutics | 2014
Fábio Gasparin; Renata Genaro Aguiar; Gabriela L. Ioshimoto; Armando Silva-Cunha; Sílvia Ligório Fialho; Andre Liber; Balázs Nagy; Nestor N. Oiwa; Marcelo Fernandes Costa; Christina Joselevitch; Dora Fix Ventura; Francisco Max Damico
PURPOSE To determine the half-life of mycophenolic acid (MPA) in the vitreous of New Zealand albino rabbits after intravitreal injection and the retinal toxicity of different doses of MPA. METHODS Ten micrograms of MPA (Roche Bioscience, Palo Alto, CA) was injected in the vitreous of 16 rabbits, animals were sacrificed at different time-points, and vitreous samples underwent high-performance liquid chromatography. For functional and morphological studies, 5 doses of MPA (0.05, 0.5, 2, 10, and 100 μg) were injected in the vitreous of 20 rabbits. As control, contralateral eyes were injected with aqueous vehicle. Electroretinograms (ERGs) were recorded before injection and at days 7, 15, and 30. Animals were sacrificed on day 30 and retinas were analyzed under light microscopy. RESULTS MPA half-life in the vitreous was 5.0±0.3 days. ERG revealed photoreceptor functional impairment in eyes injected with 0.5 μg and higher on day 30, while eyes injected with 100 μg presented the same changes already from day 15. No morphological change was found. CONCLUSIONS MPA vitreous half-life is 5.0 days. Intravitreal injection of 0.5 μg MPA and higher causes dose- and time-related photoreceptor sensitivity decrease in rabbits. The MPA dose of 0.05 μg may be safe for intravitreal use in rabbits.
Documenta Ophthalmologica | 2018
Gabriela L. Ioshimoto; Amanda Alves Camargo; Andre Liber; Balázs Nagy; Francisco Max Damico; Dora Fix Ventura
BackgroundPigmented and albino rabbits are commonly used in visual research; however, the lack of pigment in the eyes may affect retinal responses. Here, we compare and describe the differences of retinal function between pigmented (English Butterfly) and albino (New Zealand) rabbits.MethodsElectroretinograms were recorded in pigmented and albino rabbits in the dark-adapted eye, in the light-adapted eye and for four temporal frequencies in the light-adapted eye. The implicit time and amplitude of the a- and b-waves were analyzed, as well as the amplitude and phase of the first harmonic component of the photopic flicker response.ResultsAlbino rabbits presented significantly larger amplitudes for both a- and b-waves at all intensities and frequencies. The intensity–response function of the scotopic b-wave also showed that the albino retina is more sensitive than the pigmented retina and the larger flicker amplitudes found in the albino group also revealed post-receptoral changes specifically related to cone pathways.ConclusionsThe larger amplitude of albino receptoral and post-receptoral activities might be attributed to greater availability of light due to scatter and reflection at the retinal layer, and as the differences in response amplitudes between the groups increase with flicker frequency, we suggest that ON bipolar cells recover faster in the albino group, suggesting that this might be a mechanism to explain the higher temporal resolution for albinos compared to the pigmented group.
Revista do Colégio Brasileiro de Cirurgiões | 2017
Francisco Max Damico; Fábio Gasparin; Gabriela L. Ioshimoto; Thais Zamudio Igami; Armando Da Silva Cunha; Sílvia Ligório Fialho; Andre Liber; Lucy H. Young; Dora Fix Ventura
Objective: to determine the functional and morphological effects at rabbits retina of PS80 concentration used in the preparation of intravitreal drugs. Methods: eleven New Zealand rabbits received a intravitreal injection of 0.1ml of PS80. As control, the contralateral eye of each rabbit received the same volume of saline. Electroretinography was performed according to a modified protocol, as well as biomicroscopy and retina mapping before injection and seven and ten days after. Animals were euthanized in the 30th day and the retinas were analyzed by light microscopy. Results: eyes injected with PS80 did not present clinical signs of intraocular inflammation. Electroretinography did not show any alteration of extent and implicit time of a and b waves at scotopic and photopic conditions. There were no morphological alterations of retinas at light microscopy. Conclusion: intravitreal injection of PS80 in the used concentration for intravitreal drug preparations do not cause any functional or morphological alterations of rabbit retinas. These results suggest that PS80 is not toxic to rabbit retinas and may be safely used in the preparation of new lipophilic drugs for intravitreal injection.OBJECTIVE to determine the functional and morphological effects at rabbits retina of PS80 concentration used in the preparation of intravitreal drugs. METHODS eleven New Zealand rabbits received a intravitreal injection of 0.1ml of PS80. As control, the contralateral eye of each rabbit received the same volume of saline. Electroretinography was performed according to a modified protocol, as well as biomicroscopy and retina mapping before injection and seven and ten days after. Animals were euthanized in the 30th day and the retinas were analyzed by light microscopy. RESULTS eyes injected with PS80 did not present clinical signs of intraocular inflammation. Electroretinography did not show any alteration of extent and implicit time of a and b waves at scotopic and photopic conditions. There were no morphological alterations of retinas at light microscopy. CONCLUSION intravitreal injection of PS80 in the used concentration for intravitreal drug preparations do not cause any functional or morphological alterations of rabbit retinas. These results suggest that PS80 is not toxic to rabbit retinas and may be safely used in the preparation of new lipophilic drugs for intravitreal injection.
Brain Behavior and Evolution | 2013
Nina Patzke; Andrea LeRoy; Nhlanhla W. Ngubane; Nigel C. Bennett; Katarina Medger; Nadine Gravett; Consolate Kaswera-Kyamakya; Emmanuel Gilissen; Richard Chawana; Paul R. Manger; Thomas Haaf; Eberhard Schneider; Nady El Hajj; Vladimir V. Pravosudov; Dovid Y. Kozlovsky; Shelby L. Brown; Carrie L. Branch; Timothy C. Roth; Ashley R. Maine; Sean D. Powers; Deborah I. Lutterschmidt; Jeremy R. Corfield; Heather L. Eisthen; Andrew N. Iwaniuk; Stuart Parsons; Einat Hauzman; Daniela Maria Oliveira Bonci; Sonia Regina Grötzner; Maritana Mela; Andre Liber
The abstract should be restricted to 1 page and should summarize the entire paper, including the results. The term ‘will be discussed’ should be avoided, as should abbreviations and citations. Text: The text of the manuscript should comprise the following sections: Introduction, Materials and Methods, Results, and Discussion. Within each section, successive levels of subheadings (if used) should be clearly distinguished. Acknowledgments (if appropriate) should be added at the end of the text. Footnotes should be avoided; if essential, they should be numbered consecutively and typed at the bottom of the appropriate page. Citations in the text should be enclosed in [brackets], not (parentheses), and should comprise the name(s) of the author(s) – use ‘et al.’ when there are three or more – and the year of publication, in chronological order. Work in preparation is formally cited as ‘[unpublished observations]’, and these are assumed to be those of all (and only) the authors. If otherwise, first initials and last names should be used, as for ‘[personal communication]’ from a colleague, as neither appears in the References. Statistics reported in the text must include the value of the test statistic (F, t, r, etc.), the number of subjects (n) or degrees of freedom (df), and the p value (<, >, or the exact value). They should be written in one of the following forms: F = 19.44, d.f. = 6,62, p < 0.001 or F(6,62) = 19.44, p < 0.001; t = 3.73, n = 25, p < 0.01 or t(25) = 3.73, p < 0.01; r = 0.34, n = 8, p > 0.05 or r = 0.34, n = 8, n.s. Reported means must always be accompanied by the standard deviation or standard error of the mean and should be written in a form such as 702.2 mm. Tables: Each table should bear a heading incorporating the table number (in Arabic numerals) and title; if necessary, a key to symbols in the table should appear beneath the table. Figure legends: Figure legends should be numbered and listed in order. If a figure has more than one part, the legend should begin with a short description of the figure as a whole before each individual frame is described or referred to. Figures: Illustrations for publication must be professional quality drawings or photographs; negatives can not be used. Due to technical reasons, figures with a screen background should not be submitted. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1200 dpi. Color illustrations Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends. Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 800.– per page. Cover Illustration Authors may submit a suggested cover illustration after a paper has been accepted. Suggested illustrations may be black and white drawings or photographs, and must be accompanied by a one-sentence caption. References In the text identify references by authors‘ names and year of publication in parentheses. The list of references should be ordered alphabetically according to the first author’s surname of each reference. The surnames of the authors followed by initials should be given. Preferably, please cite all authors. These should be followed by the year in parentheses, the title, journal, volume and complete pagination. Abbreviate journal names according to the Index Medicus system. Examples (a) Papers published in periodicals: Sun J, Koto H, Chung KF (1997): Interaction of ozone and allergen challenges on bronchial responsiveness and inflammation in sensitised guinea pigs. Int Arch Allergy Immunol 112:191–195. (b) Monographs: Matthews DE, Farewell VT (1996): Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger. (c) Edited books: Parren PWHI, Burton DR (1997): Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy; in Capra JD (ed): Antibody Engineering. Chem Immunol. Basel, Karger, vol 65, pp 18–56. Digital Object Identifier (DOI) S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org. Supplementary Material Supplementary material is restricted to additional data that are not necessary for the scientific integrity and conclusions of the paper. Please note that all supplementary files will undergo editorial review and should be submitted together with the original manuscript. The Editors reserve the right to limit the scope and length of the supplementary material. Supplementary material must meet production quality standards for Web publication without the need for any modification or editing. In general, supplementary files should not exceed 10 MB in size. All figures and tables should have titles and legends and all files should be supplied separately and named clearly. Acceptable files and formats are: Word or PDF files, Excel spreadsheets (only if the data cannot be converted properly to a PDF file), and video files (.mov, .avi, .mpeg). Vertebrate animals If vertebrate animals are involved, the author should complete and include in the Materials and Methods section a statement similar to the following example. ‘The original research reported herein was performed under guidelines established by ... .’ Further suggestions for the preparation of manuscripts: Abbreviations should not be over-used in the text. In any case, a term should be written out the first time it is used and the abbreviation established in parentheses. Abbreviations should never be used to begin a sentence. Single authors should avoid the use of the first person plural, and all authors should give careful thought to the use of tense. For example, information may flow more smoothly to the reader if the present tense is reserved for established phenomena and the past tense used for the results being reported. Similarly, the active voice is usually preferable to the passive voice. Authors should also give thought to exact word usage. Taxonomic names and precise biological terms should be used to refer to animal groups, and vague, subjective descriptors such as ‘higher’ and ‘lower’ should be avoided. Similarly, the descriptive prefixes paleo-, archi-, and neoapplied to cerebellum, cortex, or striatum imply an invalid phylogenetic sequence and should also be avoided. In addition, authors should refrain from the use of invalid typological concepts. Instead of ‘the fish’, a more accurate and specific category is preferable: ‘the channel catfish’, ‘silurid catfishes’, ‘all teleosts examined to date’, or ‘most actinopterygian fishes’, for example. Authors are also reminded that, by definition, there are no living primitive animals, only living animals with features that are either primitive or derived, which can be determined only by appropriate phylogenetic analysis. Author’s Choice Karger’s Author’s Choice service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a onetime fee of CHF 3000.–, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice. NIH-Funded Research The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author’s Choice service, the usual embargo will be overriden, accelerating the accessibility of your work. More details on NIH’s Public Access Policy are available at http://publicaccess.nih.gov/policy.htm Self-Archiving Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution’s servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher’s version, and must acknowledge the publisher’s copyright. Authors selecting Karger’s Author’s Choice feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links. Page Charges There are no charges for papers of 10 or fewer printed pages (including tables, illustrations and references). Each additional complete or partial page is charged to the author at CHF 325.– if the author’s institution does not carry a current institutional subscription to the journal. As the page charges are waived in any case for the first paper each year to be published by a member of The J.B. Johnston Club for Evolutionary Neuroscience, authors who are members of JBJC should so indicate on the title page. Proofs Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations other than the correction of printer’s errors are charged to the author. E-pub First All articles are published electronically ahead of print with a DOI number and are supplemented later with the definite reference of the printed version. The articles become available immediately after the authors’ approval to publication, with the added advantage of being citable much earlier than in print. Authors can influence the time of appearance by promptly returning the proofs. Reprints Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher pr
Investigative Ophthalmology & Visual Science | 2015
Aline Yoshie Goto; Andre Liber; Beatriz Sayuri Takahashi; Francisco Max Damico; Dora Fix Ventura; Christina Joselevitch
Investigative Ophthalmology & Visual Science | 2015
Gabriela L. Ioshimoto; Andre Liber; Thais Zamudio Igami; Francisco Max Damico; Dora Fix Ventura
Investigative Ophthalmology & Visual Science | 2015
Andre Liber; Gabriela L. Ioshimoto; Amanda Alves Camargo; Thais Zamudio Igami; Armando Silva-Cunha; Balázs Nagy; Marcelo Fernandes Costa; Francisco Max Damico; Dora Fix Ventura
Investigative Ophthalmology & Visual Science | 2013
Andre Liber; Rafael Ferraro; Dora Fix Ventura; Francisco Max Damico; Christina Joselevitch
Investigative Ophthalmology & Visual Science | 2013
Gabriela L. Ioshimoto; Beatriz Sayuri Takahashi; Cristiano Pessoa; Andre Liber; Balázs Nagy; Dora Fix Ventura; Francisco Max Damico